Glomerular development - Shaping the multi-cellular filtration unit

Seminars in Cell and Developmental Biology

Volumn 36, Issue , 2014, Pages 39-49

  Schell, C ^a,b   Wanner, N ^a   Huber, T B ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Endothelial cell; Glomerular development; Mesangial cell; Parietal epithelial cell; Podocyte; WT1

Indexed keywords

WT1 PROTEIN;

ANGIOGENESIS; BRANCHING MORPHOGENESIS; CELL COMMUNICATION; CELL SEPARATION; DEVELOPMENTAL STAGE; ENDOTHELIUM CELL; EPITHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; GLOMERULAR STRUCTURE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HUMAN; KIDNEY DEVELOPMENT; KIDNEY FAILURE; MESANGIUM CELL; MICROARRAY ANALYSIS; PODOCYTE; REVIEW; SKELETON MALFORMATION;

EID: 85027953823     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.07.016     Document Type: Review

References (173)

1. Grahammer F., Schell C., Huber T.B. The podocyte slit diaphragm - from a thin grey line to a complex signalling hub. Nat Rev Nephrol 2013, 9:587-598.
2. Miner J.H. Organogenesis of the kidney glomerulus: focus on the glomerular basement membrane. Organogenesis 2011, 7:75-82.
3. Patrakka J., Tryggvason K. New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 2009, 5:463-468.
4. Brinkkoetter P.T., Ising C., Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol 2013, 9:328-336.
5. Costantini F., Kopan R. Patterning a complex organ: branching morphogenesis and nephron segmentation in kidney development. Dev Cell 2010, 18:698-712.
6. Dressler G.R. The cellular basis of kidney development. Annu Rev Cell Dev Biol 2006, 22:509-529.
7. Vainio S., Lin Y. Coordinating early kidney development: lessons from gene targeting. Nat Rev Genet 2002, 3:533-543.
8. Dressler G.R. Advances in early kidney specification, development and patterning. Development 2009, 136:3863-3874.
9. Faa G., Gerosa C., Fanni D., Monga G., Zaffanello M., Van Eyken P., et al. Morphogenesis and molecular mechanisms involved in human kidney development. J Cell Physiol 2012, 227:1257-1268.
10. Kitamoto Y., Tokunaga H., Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. J Clin Investig 1997, 99:2351-2357.
11. Tufro A., Norwood V.F., Carey R.M., Gomez R.A. Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol 1999, 10:2125-2134.
12. Ballermann B.J. Glomerular endothelial cell differentiation. Kidney Int 2005, 67:1668-1671.
13. Masuya M., Drake C.J., Fleming P.A., Reilly C.M., Zeng H., Hill W.D., et al. Hematopoietic origin of glomerular mesangial cells. Blood 2003, 101:2215-2218.
14. Kobayashi A., Valerius M.T., Mugford J.W., Carroll T.J., Self M., Oliver G., et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008, 3:169-181.
15. Schnabel E., Anderson J.M., Farquhar M.G. The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol 1990, 111:1255-1263.
16. Tassin M.T., Beziau A., Gubler M.C., Boyer B. Spatiotemporal expression of molecules associated with junctional complexes during the in vivo maturation of renal podocytes. Int J Dev Biol 1994, 38:45-54.
17. Holzman L.B., St John P.L., Kovari I.A., Verma R., Holthofer H., Abrahamson D.R. Nephrin localizes to the slit pore of the glomerular epithelial cell. Kidney Int 1999, 56:1481-1491.
18. Ruotsalainen V., Patrakka J., Tissari P., Reponen P., Hess M., Kestila M., et al. Role of nephrin in cell junction formation in human nephrogenesis. Am J Pathol 2000, 157:1905-1916.
19. Liu G., Kaw B., Kurfis J., Rahmanuddin S., Kanwar Y.S., Chugh S.S. Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Investig 2003, 112:209-221.
20. Doyonnas R., Kershaw D.B., Duhme C., Merkens H., Chelliah S., Graf T., et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 2001, 194:13-27.
21. Shono A., Tsukaguchi H., Yaoita E., Nameta M., Kurihara H., Qin X.S., et al. Podocin participates in the assembly of tight junctions between foot processes in nephrotic podocytes. J Am Soc Nephrol 2007, 18:2525-2533.
22. Pieczynski J., Margolis B. Protein complexes that control renal epithelial polarity. Am J Physiol Ren Physiol 2011, 300:F589-F601.
23. Simons M., Hartleben B., Huber T.B. Podocyte polarity signalling. Curr Opin Nephrol Hypertens 2009, 18:324-330.
24. Hartleben B., Schweizer H., Lubben P., Bartram M.P., Moller C.C., Herr R., et al. Neph-Nephrin proteins bind the Par3-Par6-atypical protein kinase C (aPKC) complex to regulate podocyte cell polarity. J Biol Chem 2008, 283:23033-23038.
25. Hirose T., Satoh D., Kurihara H., Kusaka C., Hirose H., Akimoto K., et al. An essential role of the universal polarity protein, aPKClambda, on the maintenance of podocyte slit diaphragms. PLoS One 2009, 4:e4194.
26. Huber T.B., Hartleben B., Winkelmann K., Schneider L., Becker J.U., Leitges M., et al. Loss of podocyte aPKClambda/iota causes polarity defects and nephrotic syndrome. J Am Soc Nephrol 2009, 20:798-806.
27. Hartleben B., Widmeier E., Suhm M., Worthmann K., Schell C., Helmstadter M., et al. aPKClambda/iota and aPKCzeta contribute to podocyte differentiation and glomerular maturation. J Am Soc Nephrol 2013, 24:253-267.
28. Ebarasi L., He L., Hultenby K., Takemoto M., Betsholtz C., Tryggvason K., et al. A reverse genetic screen in the zebrafish identifies crb2b as a regulator of the glomerular filtration barrier. Dev Biol 2009, 334:1-9.
29. Hartleben B., Widmeier E., Wanner N., Schmidts M., Kim S.T., Schneider L., et al. Role of the polarity protein Scribble for podocyte differentiation and maintenance. PLOS ONE 2012, 7:e36705.
30. Kriz W., Shirato I., Nagata M., LeHir M., Lemley K.V. The podocyte's response to stress: the enigma of foot process effacement. Am J Physiol Ren Physiol 2013, 304:F333-F347.
31. Shirato I., Sakai T., Kimura K., Tomino Y., Kriz W. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis. Am J Pathol 1996, 148:1283-1296.
32. Shirato I. Podocyte process effacement in vivo. Microsc Res Tech 2002, 57:241-246.
33. Welsh G.I., Saleem M.A. The podocyte cytoskeleton - key to a functioning glomerulus in health and disease. Nat Rev Nephrol 2012, 8:14-21.
34. Kobayashi N., Gao S.Y., Chen J., Saito K., Miyawaki K., Li C.Y., et al. Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons?. Anat Sci Int 2004, 79:1-10.
35. Sun Y., Zhang H., Hu R., Sun J., Mao X., Zhao Z., et al. The expression and significance of neuronal iconic proteins in podocytes. PLOS ONE 2014, 9:e93999.
36. Chen J., Boyle S., Zhao M., Su W., Takahashi K., Davis L., et al. Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. J Am Soc Nephrol 2006, 17:1283-1291.
37. Patrakka J., Xiao Z., Nukui M., Takemoto M., He L., Oddsson A., et al. Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik. J Am Soc Nephrol 2007, 18:689-697.
38. Mundel P., Heid H.W., Mundel T.M., Kruger M., Reiser J., Kriz W. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 1997, 139:193-204.
39. Kreidberg J.A. Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol 2003, 14:806-814.
40. Vasioukhin V., Bauer C., Yin M., Fuchs E. Directed actin polymerization is the driving force for epithelial cell-cell adhesion. Cell 2000, 100:209-219.
41. Hackl M.J., Burford J.L., Villanueva K., Lam L., Susztak K., Schermer B., et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med 2013, 19:1661-1666.
42. Endlich N., Simon O., Gopferich A., Wegner H., Moeller M.J., Rumpel E., et al. Two-photon microscopy reveals stationary podocytes in living zebrafish larvae. J Am Soc Nephrol 2014, 25:681-686.
43. Puram S.V., Bonni A. Cell-intrinsic drivers of dendrite morphogenesis. Development 2013, 140:4657-4671.
44. Orlando R.A., Takeda T., Zak B., Schmieder S., Benoit V.M., McQuistan T., et al. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 2001, 12:1589-1598.
45. Jones N., Blasutig I.M., Eremina V., Ruston J.M., Bladt F., Li H., et al. Nck adaptor proteins link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006, 440:818-823.
46. Vinzenz M., Nemethova M., Schur F., Mueller J., Narita A., Urban E., et al. Actin branching in the initiation and maintenance of lamellipodia. J Cell Sci 2012, 125:2775-2785.
47. Schell C., Baumhakl L., Salou S., Conzelmann A.C., Meyer C., Helmstadter M., et al. N-wasp is required for stabilization of podocyte foot processes. J Am Soc Nephrol 2013, 24:713-721.
48. Scott R.P., Hawley S.P., Ruston J., Du J., Brakebusch C., Jones N., et al. Podocyte-specific loss of Cdc42 leads to congenital nephropathy. J Am Soc Nephrol 2012, 23:1149-1154.
49. Blattner S.M., Hodgin J.B., Nishio M., Wylie S.A., Saha J., Soofi A.A., et al. Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury. Kidney Int 2013, 84:920-930.
50. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 2006, 16:522-529.
51. Hyink D.P., Tucker D.C., St John P.L., Leardkamolkarn V., Accavitti M.A., Abrass C.K., et al. Endogenous origin of glomerular endothelial and mesangial cells in grafts of embryonic kidneys. Am J Physiol 1996, 270:F886-F899.
52. Robert B., Zhao X., Abrahamson D.R. Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am J Physiol Ren Physiol 2000, 279:F275-F282.
53. Abrahamson D.R. Glomerulogenesis in the developing kidney. Semin Nephrol 1991, 11:375-389.
54. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Investig 2003, 111:707-716.
55. Sugimoto H., Hamano Y., Charytan D., Cosgrove D., Kieran M., Sudhakar A., et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003, 278:12605-12608.
56. Veron D., Reidy K.J., Bertuccio C., Teichman J., Villegas G., Jimenez J., et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int 2010, 77:989-999.
57. Rohr C., Prestel J., Heidet L., Hosser H., Kriz W., Johnson R.L., et al. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J Clin Investig 2002, 109:1073-1082.
58. Kim S.I., Lee S.Y., Wang Z., Ding Y., Haque N., Zhang J., et al. TGF-beta-activated kinase 1 Is crucial in podocyte differentiation and glomerular capillary formation. J Am Soc Nephrol 2014, [Epub ahead of print].
59. Satchell S.C., Harper S.J., Tooke J.E., Kerjaschki D., Saleem M.A., Mathieson P.W. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002, 13:544-550.
60. Kolatsi-Joannou M., Li X.Z., Suda T., Yuan H.T., Woolf A.S. Expression and potential role of angiopoietins and Tie-2 in early development of the mouse metanephros. Dev Dyn 2001, 222:120-126.
61. Takahashi T., Takahashi K., Gerety S., Wang H., Anderson D.J., Daniel T.O. Temporally compartmentalized expression of ephrin-B2 during renal glomerular development. J Am Soc Nephrol 2001, 12:2673-2682.
62. McCright B., Gao X., Shen L., Lozier J., Lan Y., Maguire M., et al. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128:491-502.
63. Sudarsan V., Pasalodos-Sanchez S., Wan S., Gampel A., Skaer H. A genetic hierarchy establishes mitogenic signalling and mitotic competence in the renal tubules of Drosophila. Development 2002, 129:935-944.
64. McLaughlin K.A., Rones M.S., Mercola M. Notch regulates cell fate in the developing pronephros. Dev Biol 2000, 227:567-580.
65. McCright B. Notch signaling in kidney development. Curr Opin Nephrol Hypertens 2003, 12:5-10.
66. Fierlbeck W., Liu A., Coyle R., Ballermann B.J. Endothelial cell apoptosis during glomerular capillary lumen formation in vivo. J Am Soc Nephrol 2003, 14:1349-1354.
67. Roberts W.G., Palade G.E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res 1997, 57:765-772.
68. Roberts W.G., Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995, 108(Pt 6):2369-2379.
69. Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992, 114:521-532.
70. Paulsson M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit Rev Biochem Mol Biol 1992, 27:93-127.
71. Miner J.H. Glomerular basement membrane composition and the filtration barrier. Pediatr Nephrol 2011, 26:1413-1417.
72. Price R.G., Spiro R.G. Studies on the metabolism of the renal glomerular basement membrane. Turnover measurements in the rat with the use of radiolabeled amino acids. J Biol Chem 1977, 252:8597-8602.
73. St John P.L., Abrahamson D.R. Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains. Kidney Int 2001, 60:1037-1046.
74. St John P.L., Wang R., Yin Y., Miner J.H., Robert B., Abrahamson D.R. Glomerular laminin isoform transitions: errors in metanephric culture are corrected by grafting. Am J Physiol Ren Physiol 2001, 280:F695-F705.
75. Miner J.H. Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 1998, 7:13-19.
76. Abrahamson D.R., Hudson B.G., Stroganova L., Borza D.B., St John P.L. Cellular origins of type IV collagen networks in developing glomeruli. J Am Soc Nephrol 2009, 20:1471-1479.
77. Miner J.H., Sanes J.R. Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol 1994, 127:879-891.
78. Alport A.C. Hereditary familial congenital haemorrhagic nephritis. Br Med J 1927, 1:504-506.
79. Kruegel J., Rubel D., Gross O. Alport syndrome - insights from basic and clinical research. Nat Rev Nephrol 2013, 9:170-178.
80. Abrahamson D.R., St John P.L., Stroganova L., Zelenchuk A., Steenhard B.M. Laminin and type IV collagen isoform substitutions occur in temporally and spatially distinct patterns in developing kidney glomerular basement membranes. J Histochem Cytochem 2013, 61:706-718.
81. Abrahamson D.R. Role of the podocyte (and glomerular endothelium) in building the GBM. Semin Nephrol 2012, 32:342-349.
82. Mugford J.W., Sipila P., McMahon J.A., McMahon A.P. Osr1 expression demarcates a multi-potent population of intermediate mesoderm that undergoes progressive restriction to an Osr1-dependent nephron progenitor compartment within the mammalian kidney. Dev Biol 2008, 324:88-98.
83. Lindahl P., Hellstrom M., Kalen M., Karlsson L., Pekny M., Pekna M., et al. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998, 125:3313-3322.
84. Betsholtz C., Lindblom P., Bjarnegard M., Enge M., Gerhardt H., Lindahl P. Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr Opin Nephrol Hypertens 2004, 13:45-52.
85. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994, 8:1875-1887.
86. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994, 8:1888-1896.
87. Bohnenpoll T., Bettenhausen E., Weiss A.C., Foik A.B., Trowe M.O., Blank P., et al. Tbx18 expression demarcates multipotent precursor populations in the developing urogenital system but is exclusively required within the ureteric mesenchymal lineage to suppress a renal stromal fate. Dev Biol 2013, 380:25-36.
88. Xu J., Nie X., Cai X., Cai C.L., Xu P.X. Tbx18 is essential for normal development of vasculature network and glomerular mesangium in the mammalian kidney. Dev Biol 2014, 391:17-31.
89. Boyle S.C., Liu Z., Kopan R. Notch signaling is required for the formation of mesangial cells from a stromal mesenchyme precursor during kidney development. Development 2014, 141:346-354.
90. Kikkawa Y., Virtanen I., Miner J.H. Mesangial cells organize the glomerular capillaries by adhering to the G domain of laminin alpha5 in the glomerular basement membrane. J Cell Biol 2003, 161:187-196.
91. Ohse T., Pippin J.W., Chang A.M., Krofft R.D., Miner J.H., Vaughan M.R., et al. The enigmatic parietal epithelial cell is finally getting noticed: a review. Kidney Int 2009, 76:1225-1238.
92. Dijkman H.B., Weening J.J., Smeets B., Verrijp K.C., van Kuppevelt T.H., Assmann K.K., et al. Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 2006, 70:338-344.
93. Wilkinson L., Gilbert T., Kinna G., Ruta L.A., Pennisi D., Kett M., et al. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor - a activity during glomerular vascular development. J Am Soc Nephrol 2007, 18:1697-1708.
94. Drummond I.A., Mukhopadhyay D., Sukhatme V.P. Expression of fetal kidney growth factors in a kidney tumor line: role of FGF2 in kidney development. Exp Nephrol 1998, 6:522-533.
95. Shirato I., Asanuma K., Takeda Y., Hayashi K., Tomino Y. Protein gene product 9.5 is selectively localized in parietal epithelial cells of Bowman's capsule in the rat kidney. J Am Soc Nephrol 2000, 11:2381-2386.
96. Burnworth B., Pippin J., Karna P., Akakura S., Krofft R., Zhang G., et al. SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab Investig 2012, 92:499-510.
97. Kiuchi-Saishin Y., Gotoh S., Furuse M., Takasuga A., Tano Y., Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 2002, 13:875-886.
98. Bariety J., Mandet C., Hill G.S., Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006, 17:2770-2780.
99. Gibson I.W., Downie I., Downie T.T., Han S.W., More I.A., Lindop G.B. The parietal podocyte: a study of the vascular pole of the human glomerulus. Kidney Int 1992, 41:211-214.
100. Ronconi E., Sagrinati C., Angelotti M.L., Lazzeri E., Mazzinghi B., Ballerini L., et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 2009, 20:322-332.
101. Angelotti M.L., Ronconi E., Ballerini L., Peired A., Mazzinghi B., Sagrinati C., et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 2012, 30:1714-1725.
102. Sakamoto K., Ueno T., Kobayashi N., Hara S., Takashima Y., Pastan I., et al. The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis. Am J Physiol Ren Physiol 2014, 306:F98-F104.
103. Grouls S., Iglesias D.M., Wentzensen N., Moeller M.J., Bouchard M., Kemler R., et al. Lineage specification of parietal epithelial cells requires beta-catenin/Wnt signaling. J Am Soc Nephrol 2012, 23:63-72.
104. Wanner N., Hartleben B., Herbach N., Goedel M., Stickel N., Zeiser R., et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol 2014, 25:707-716.
105. Appel D., Kershaw D.B., Smeets B., Yuan G., Fuss A., Frye B., et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol 2009, 20:333-343.
106. Berger K., Schulte K., Boor P., Kuppe C., van Kuppevelt T.H., Floege J., et al. The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol 2014, 25:693-705.
107. Smeets B., Uhlig S., Fuss A., Mooren F., Wetzels J.F., Floege J., et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol 2009, 20:2604-2615.
108. Smeets B., Kuppe C., Sicking E.M., Fuss A., Jirak P., van Kuppevelt T.H., et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol 2011, 22:1262-1274.
109. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990, 60:509-520.
110. Kreidberg J.A., Sariola H., Loring J.M., Maeda M., Pelletier J., Housman D., et al. WT-1 is required for early kidney development. Cell 1993, 74:679-691.
111. Pelletier J., Bruening W., Kashtan C.E., Mauer S.M., Manivel J.C., Striegel J.E., et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991, 67:437-447.
112. Riccardi V.M., Sujansky E., Smith A.C., Francke U. Chromosomal imbalance in the aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 1978, 61:604-610.
113. Ton C.C., Hirvonen H., Miwa H., Weil M.M., Monaghan P., Jordan T., et al. Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell 1991, 67:1059-1074.
114. Baird P.N., Groves N., Haber D.A., Housman D.E., Cowell J.K. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. Oncogene 1992, 7:2141-2149.
115. Jordan T., Hanson I., Zaletayev D., Hodgson S., Prosser J., Seawright A., et al. The human PAX6 gene is mutated in two patients with aniridia. Nat Genet 1992, 1:328-332.
116. Pelletier J., Bruening W., Li F.P., Haber D.A., Glaser T., Housman D.E. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature 1991, 353:431-434.
117. Drash A., Sherman F., Hartmann W.H., Blizzard R.M. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 1970, 76:585-593.
118. Bruening W., Bardeesy N., Silverman B.L., Cohn R.A., Machin G.A., Aronson A.J., et al. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat Genet 1992, 1:144-148.
119. Schneider S., Wildhardt G., Ludwig R., Royer-Pokora B. Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations. Hum Genet 1993, 91:599-604.
120. Patek C.E., Little M.H., Fleming S., Miles C., Charlieu J.P., Clarke A.R., et al. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci U S A 1999, 96:2931-2936.
121. Klamt B., Koziell A., Poulat F., Wieacker P., Scambler P., Berta P., et al. Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1+-KTS splice isoforms. Hum Mol Genet 1998, 7:709-714.
122. Barbaux S., Niaudet P., Gubler M.C., Grunfeld J.P., Jaubert F., Kuttenn F., et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997, 17:467-470.
123. Hammes A., Guo J.K., Lutsch G., Leheste J.R., Landrock D., Ziegler U., et al. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 2001, 106:319-329.
124. Gwin K., Cajaiba M.M., Caminoa-Lizarralde A., Picazo M.L., Nistal M., Reyes-Mugica M. Expanding the clinical spectrum of Frasier syndrome. Pediatr Dev Pathol 2008, 11:122-127.
125. Martinez-Estrada O.M., Lettice L.A., Essafi A., Guadix J.A., Slight J., Velecela V., et al. Wt1 is required for cardiovascular progenitor cell formation through transcriptional control of Snail and E-cadherin. Nat Genet 2010, 42:89-93.
126. Essafi A., Webb A., Berry R.L., Slight J., Burn S.F., Spraggon L., et al. A wt1-controlled chromatin switching mechanism underpins tissue-specific wnt4 activation and repression. Dev Cell 2011, 21:559-574.
127. Guo G., Morrison D.J., Licht J.D., Quaggin S.E. WT1 activates a glomerular-specific enhancer identified from the human nephrin gene. J Am Soc Nephrol 2004, 15:2851-2856.
128. Palmer R.E., Kotsianti A., Cadman B., Boyd T., Gerald W., Haber D.A. WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin. Curr Biol 2001, 11:1805-1809.
129. Ratelade J., Arrondel C., Hamard G., Garbay S., Harvey S., Biebuyck N., et al. A murine model of Denys-Drash syndrome reveals novel transcriptional targets of WT1 in podocytes. Hum Mol Genet 2010, 19:1-15.
130. Schumacher V.A., Schlotzer-Schrehardt U., Karumanchi S.A., Shi X., Zaia J., Jeruschke S., et al. WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier. J Am Soc Nephrol 2011, 22:1286-1296.
131. Yang Y., Jeanpierre C., Dressler G.R., Lacoste M., Niaudet P., Gubler M.C. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 1999, 154:181-192.
132. Gao X., Chen X., Taglienti M., Rumballe B., Little M.H., Kreidberg J.A. Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa. Development 2005, 132:5437-5449.
133. Natoli T.A., Liu J., Eremina V., Hodgens K., Li C., Hamano Y., et al. A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development. J Am Soc Nephrol 2002, 13:2058-2067.
134. Amin E.M., Oltean S., Hua J., Gammons M.V., Hamdollah-Zadeh M., Welsh G.I., et al. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 2011, 20:768-780.
135. Cunningham T.J., Palumbo I., Grosso M., Slater N., Miles C.G. WT1 regulates murine hematopoiesis via maintenance of VEGF isoform ratio. Blood 2013, 122:188-192.
136. Gebeshuber C.A., Kornauth C., Dong L., Sierig R., Seibler J., Reiss M., et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med 2013, 19:481-487.
137. Chen H., Lun Y., Ovchinnikov D., Kokubo H., Oberg K.C., Pepicelli C.V., et al. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 1998, 19:51-55.
138. Dreyer S.D., Zhou G., Baldini A., Winterpacht A., Zabel B., Cole W., et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998, 19:47-50.
139. Lemley K.V. Kidney disease in nail-patella syndrome. Pediatr Nephrol 2009, 24:2345-2354.
140. Hawkins C.F., Smith O.E. Renal dysplasia in a family with multiple hereditary abnormalities including iliac horns. Lancet 1950, 1:803-808.
141. Burghardt T., Kastner J., Suleiman H., Rivera-Milla E., Stepanova N., Lottaz C., et al. LMX1B is essential for the maintenance of differentiated podocytes in adult kidneys. J Am Soc Nephrol 2013, 24:1830-1848.
142. Isojima T., Harita Y., Furuyama M., Sugawara N., Ishizuka K., Horita S., et al. LMX1B mutation with residual transcriptional activity as a cause of isolated glomerulopathy. Nephrol Dial Transplant 2014, 29:81-88.
143. Boyer O., Woerner S., Yang F., Oakeley E.J., Linghu B., Gribouval O., et al. LMX1B mutations cause hereditary FSGS without extrarenal involvement. J Am Soc Nephrol 2013, 24:1216-1222.
144. Quaggin S.E., Schwartz L., Cui S., Igarashi P., Deimling J., Post M., et al. The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999, 126:5771-5783.
145. Sadl V., Jin F., Yu J., Cui S., Holmyard D., Quaggin S., et al. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol 2002, 249:16-29.
146. Cui S., Schwartz L., Quaggin S.E. Pod1 is required in stromal cells for glomerulogenesis. Dev Dyn 2003, 226:512-522.
147. Cui S., Li C., Ema M., Weinstein J., Quaggin S.E. Rapid isolation of glomeruli coupled with gene expression profiling identifies downstream targets in Pod1 knockout mice. J Am Soc Nephrol 2005, 16:3247-3255.
148. Maezawa Y., Onay T., Scott R.P., Keir L.S., Dimke H., Li C., et al. Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGS. J Am Soc Nephrol 2014, [Epub ahead of print].
149. Sadl V.S., Sing A., Mar L., Jin F., Cordes S.P. Analysis of hindbrain patterning defects caused by the kreisler(enu) mutation reveals multiple roles of Kreisler in hindbrain segmentation. Dev Dyn 2003, 227:134-142.
150. Moriguchi T., Hamada M., Morito N., Terunuma T., Hasegawa K., Zhang C., et al. MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol 2006, 26:5715-5727.
151. Morito N., Yoh K., Ojima M., Okamura M., Nakamura M., Hamada M., et al. Overexpression of Mafb in podocytes protects against diabetic nephropathy. J Am Soc Nephrol 2014, [Epub ahead of print].
152. Brunskill E.W., Georgas K., Rumballe B., Little M.H., Potter S.S. Defining the molecular character of the developing and adult kidney podocyte. PLoS ONE 2011, 6:e24640.
153. Hagman J., Ramirez J., Lukin K. B lymphocyte lineage specification, commitment and epigenetic control of transcription by early B cell factor 1. Curr Top Microbiol Immunol 2012, 356:17-38.
154. Fretz J.A., Nelson T., Velazquez H., Xi Y., Moeckel G.W., Horowitz M.C. Early B-cell factor 1 is an essential transcription factor for postnatal glomerular maturation. Kidney Int 2014, 85:1091-1102.
155. James R.G., Kamei C.N., Wang Q., Jiang R., Schultheiss T.M. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells. Development 2006, 133:2995-3004.
156. Tomar R., Mudumana S.P., Pathak N., Hukriede N.A., Drummond I.A. osr1 is required for podocyte development downstream of wt1a. J Am Soc Nephrol 2014, [Epub ahead of print].
157. Kobayashi A., Kwan K.M., Carroll T.J., McMahon A.P., Mendelsohn C.L., Behringer R.R. Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development. Development 2005, 132:2809-2823.
158. Takemoto M., He L., Norlin J., Patrakka J., Xiao Z., Petrova T., et al. Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J 2006, 25:1160-1174.
159. O'Brien L.L., Grimaldi M., Kostun Z., Wingert R.A., Selleck R., Davidson A.J. Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish. Dev Biol 2011, 358:318-330.
160. White J.T., Zhang B., Cerqueira D.M., Tran U., Wessely O. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus. Development 2010, 137:1863-1873.
161. He B., Ebarasi L., Zhao Z., Guo J., Ojala J.R., Hultenby K., et al. Lmx1b and FoxC combinatorially regulate podocin expression in podocytes. J Am Soc Nephrol 2014, [Epub ahead of print].
162. Lefebvre V., Dumitriu B., Penzo-Mendez A., Han Y., Pallavi B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 2007, 39:2195-2214.
163. Hartwig S., Ho J., Pandey P., Macisaac K., Taglienti M., Xiang M., et al. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development. Development 2010, 137:1189-1203.
164. Huang J., Arsenault M., Kann M., Lopez-Mendez C., Saleh M., Wadowska D., et al. The transcription factor Sry-related HMG box-4 (SOX4) is required for normal renal development in vivo. Dev Dyn 2013, 242:790-799.
165. Borggrefe T., Oswald F. The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell Mol Life Sci 2009, 66:1631-1646.
166. Kamath B.M., Spinner N.B., Rosenblum N.D. Renal involvement and the role of Notch signalling in Alagille syndrome. Nat Rev Nephrol 2013, 9:409-418.
167. Cheng H.T., Miner J.H., Lin M., Tansey M.G., Roth K., Kopan R. Gamma-secretase activity is dispensable for mesenchyme-to-epithelium transition but required for podocyte and proximal tubule formation in developing mouse kidney. Development 2003, 130:5031-5042.
168. Wang P., Pereira F.A., Beasley D., Zheng H. Presenilins are required for the formation of comma- and S-shaped bodies during nephrogenesis. Development 2003, 130:5019-5029.
169. Cheng H.T., Kim M., Valerius M.T., Surendran K., Schuster-Gossler K., Gossler A., et al. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 2007, 134:801-811.
170. Bonegio R.G., Beck L.H., Kahlon R.K., Lu W., Salant D.J. The fate of Notch-deficient nephrogenic progenitor cells during metanephric kidney development. Kidney Int 2011, 79:1099-1112.
171. Liu Z., Chen S., Boyle S., Zhu Y., Zhang A., Piwnica-Worms D.R., et al. The extracellular domain of Notch2 increases its cell-surface abundance and ligand responsiveness during kidney development. Dev Cell 2013, 25:585-598.
172. Dressler G.R., Patel S.R. Epigenetics in kidney development and renal disease. Transl Res 2014, [Epub ahead of print].
173. Bechtel-Walz W., Huber T.B. Chromatin dynamics in kidney development and function. Cell Tissue Res 2014, 356:601-608.